Amgen Provides Updated Information On LUMAKRAS™ (Sotorasib)¹ Dose Comparison StudyPRNewsWire • 04/28/21
Amgen Inc. (AMGN) CEO Robert Bradway on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 04/28/21
Week 17 MDA Breakout Stocks - April 2021: Short-Term Picks To Give You An EdgeSeeking Alpha • 04/25/21
OTEZLA® (apremilast) Significantly Improved Measures Of Disease Severity In Adults With Mild-To-Moderate Plaque PsoriasisPRNewsWire • 04/23/21
Amgen's Investigational Targeted Treatment Bemarituzumab Granted Breakthrough Therapy DesignationPRNewsWire • 04/19/21